GSK plc (GSK) — Financial statements
Income statement, balance sheet, and cash flow for GSK plc — annual and quarterly history with growth and margin analysis.
| Metric (GBP Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 32,667↑4.1% | 31,376↑3.5% | 30,328↑3.4% | 29,324↑18.7% | 24,696 | |
| Cost of Revenue | 9,017↓0.3% | 9,048↑5.6% | 8,565↓10.4% | 9,554↑17.0% | 8,163 | |
| Gross Profit | 23,650↑5.9% | 22,328↑2.6% | 21,763↑10.1% | 19,770↑19.6% | 16,533 | |
| Operating Expenses | ||||||
| R&D Expenses | 7,525↑17.6% | 6,401↑2.9% | 6,223↑13.4% | 5,488↑9.3% | 5,019 | |
| General & Administrative Expenses | 9,088↓17.5% | 11,015↑17.4% | 9,385↑12.1% | 8,372↑18.4% | 7,070 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 9,088↓17.5% | 11,015↑17.4% | 9,385↑12.1% | 8,372↑18.4% | 7,070 | |
| Other Expenses | -1,301↓246.0% | 891↑251.0% | -590↓12.8% | -523↓701.1% | 87 | |
| Operating Expenses | 15,312↓16.4% | 18,307↑21.9% | 15,018↑12.6% | 13,337↑9.5% | 12,176 | |
| Total Costs & Expenses | 24,329↓11.1% | 27,355↑16.0% | 23,583↑3.0% | 22,891↑12.5% | 20,339 | |
| Operating Results | ||||||
| Operating Income | 8,338↑107.4% | 4,021↓40.4% | 6,745↑4.8% | 6,433↑47.6% | 4,357 | |
| Depreciation & Amortization | 2,314↓9.3% | 2,551↑11.2% | 2,294↑6.8% | 2,147↑1.2% | 2,122 | |
| EBITDA | 10,402↑56.0% | 6,668↓26.6% | 9,083↑5.6% | 8,601↑32.6% | 6,485 | |
| EBIT | 8,088↑96.5% | 4,117↓39.4% | 6,789↑5.2% | 6,454↑47.9% | 4,363 | |
| Interest & Other Income | ||||||
| Net Interest Income | -631↓6.9% | -590↑19.7% | -735↑7.1% | -791↓4.8% | -755 | |
| Interest Income | 56↓16.9% | 67↑68.5% | 40↓37.8% | 64↑129.5% | 28 | |
| Interest Expense | 687↑4.5% | 658↓15.2% | 775↓9.4% | 856↑9.1% | 784 | |
| Non-Operating Income | 250↑360.4% | -96↓118.2% | -44↓109.5% | -21↓250.0% | -6 | |
| Other Income / Expenses | -937↓72.2% | -544↑20.1% | -681↑15.4% | -805↓6.2% | -758 | |
| Income Before Tax | 7,401↑112.9% | 3,477↓42.7% | 6,064↑7.7% | 5,628↑56.4% | 3,599 | |
| Income Tax Expense | 1,112↑111.4% | 526↓30.4% | 756↑6.9% | 707↑751.8% | 83 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 6,289↑113.1% | 2,951↓44.4% | 5,308↑7.9% | 4,921↑40.0% | 3,516 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00↓100.0% | 10,700↑577.2% | 1,580 | |
| Net Income | 5,716↑122.0% | 2,575↓47.7% | 4,928↓67.1% | 14,956↑241.1% | 4,385 | |
| Bottom-Line Net Income | 5,716↑122.0% | 2,575↓47.7% | 4,928↓67.1% | 14,956↑241.1% | 4,385 | |
| EPS (Basic) | 5.64↑347.6% | 1.26↓48.4% | 2.44↑0.0% | 2.44↓10.9% | 2.74 | |
| EPS (Diluted) | 5.56↑348.4% | 1.24↓48.3% | 2.40↑0.0% | 2.40↓11.1% | 2.70 | |
| Weighted Average Shares | 1,013↓50.3% | 2,039↑0.6% | 2,026↑0.6% | 2,013↑25.7% | 1,601 | |
| Weighted Average Diluted Shares | 1,029↓50.3% | 2,071↑0.8% | 2,056↑0.7% | 2,042↑26.0% | 1,621 | |
* All figures in Millions of GBP, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.